Skip Navigation

“We made huge progress on our growth strategy in 2013, and, as a result, Mosaic is positioned to emerge, in a stronger business environment, as the world’s leading crop nutrition company.”

Jim Prokopanko President and CEO

Two-year Financial Overview

  • Calendar Year In Millions (except per share amounts)
  • CY2012
  • CY2013
  • Net Sales
  • $10,044.0
  • $9,021.4
  • Gross Margin
  • 2,729.7
  • 2,015.4
  • Operating Earnings
  • 2,203.4
  • 1,339.9
  • Net Earnings
  • 1,852.1
  • 1,062.9
  • Diluted Net Earnings Per Share
  • 4.34
  • 2.49
  • Cash and Cash Equivalents
  • 3,405.3
  • 5,293.1
  • Total Assets
  • 17,438.4
  • 19,554.0
  • Total Long-term Debt
  • 1,010.6
  • 3,009.3
  • Total Equity
  • 13,083.2
  • 11,320.6
  • Net Cash Provided by Operating Activities
  • 2,269.9
  • 2,019.9
  • Capital Expenditures
  • 1,674.7
  • 1,426.6
  • Dividends Per Share on Common Stock
  • 0.68
  • 1.00

Printable PDF
2013 Annual Report 10K